Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Main Capital targets $5bn fundraise and continuation vehicle growth amid renewed LP appetite
Main Capital targets $5bn fundraise and continuation vehicle growth amid renewed LP appetite Main Capital Partners’ Managing Partner, Charly Zwemstra, believes that in private equity, focus outperforms diversification. Speaking during his keynote at the Benelux...
Blackstone taps private credit market for £1.1bn Clarion dividend recap
Blackstone taps private credit market for £1.1bn Clarion dividend recap Blackstone’s Clarion Events is in talks with private credit lenders to raise around £1.1bn ($1.5bn) to fund a dividend payout and refinance existing debt, according to people familiar with the...
Apollo- and Vistria-backed University of Phoenix owner jumps 19% in $1.35bn NYSE debut
Apollo- and Vistria-backed University of Phoenix owner jumps 19% in $1.35bn NYSE debut Phoenix Education Partners, owner of the University of Phoenix, saw its shares rise 19% in its New York Stock Exchange debut, valuing the company at approximately $1.35bn, according...




